| Risk Adapted SABR(SABR) in Stage I NSCLC And Lung Metastases (NCT01823003) | Institut Català d'Oncologia | 2012-06-01 |
| Non-interventional Observational Study of Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Cancer (NCT02228356) | Universitair Ziekenhuis Brussel | 2012-06-01 |
| Letrozole and Lapatinib Followed by Everolimus in Women With Advanced Breast Cancer (NCT01499160) | University of Maryland, Baltimore | 2012-05-01 |
| A Prospective Study of Clinical Outcomes for the Pathwork Tissue of Origin Test (NCT01649453) | Cedar Associates LLC | 2012-05-01 |
| Fractionated Radiosurgery for Painful Spinal Metastases (NCT01594892) | Wuerzburg University Hospital | 2012-04-01 |
| A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC (NCT03303495) | Sun Yat-sen University | 2011-11-14 |
| Safety and Efficacy of Cryoablation for the Palliation of Painful Bone Metastases (NCT01461265) | Boston Scientific Corporation | 2011-11-01 |
| Lux-Breast 3; Afatinib Alone or in Combination With Vinorelbine in Patients With Human Epidermal Growth Factor Receptor 2 (HER2) Positive Breast Cancer Suffering From Brain Metastases (NCT01441596) | Boehringer Ingelheim | 2011-10-01 |
| ECI301 and Radiation for Advanced or Metastatic Cancer (NCT01441115) | National Cancer Institute (NCI) | 2011-09-06 |
| Study of Chemotherapy With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients (NCT01395056) | Peking University Cancer Hospital & Institute | 2011-07-01 |
| A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer (NCT01373164) | Eli Lilly and Company | 2011-06-01 |
| Biomarker Development for Response Prediction by DNA Mutational Analysis (NCT01855061) | P.O. Witteveen | 2011-05-01 |
| Study to Assess Safety and Tolerability of Oral CC-115 for Patients With Advanced Solid Tumors, and Hematologic Malignancies. (NCT01353625) | Celgene | 2011-04-25 |
| Pilot Study of Irreversible Electroporation (IRE) to Treat Metastatic Liver Cancer & Cholangiocarcinoma (NCT01442324) | Azienda Ospedaliera di Padova | 2011-02-01 |
| Hepatic Artery Infusion Pump for NPC Liver Metastases (NCT03876574) | Xiangya Hospital of Central South University | 2011-01-01 |
| Gene Expression Profiling of Breast Cancer Cells Predict the Response of Malignant Pleural Effusion (NCT01256801) | Peking University Cancer Hospital & Institute | 2010-11-01 |
| Study of Everolimus in the Treatment of Advanced Malignancies in Patients With Peutz-Jeghers Syndrome (NCT01178151) | Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) | 2010-10-01 |
| Whole Brain Radiation Therapy With Boost to Metastatic Tumor Volume Using RapidArc (NCT01218542) | Emory University | 2010-09-22 |
| Study of High-dose Chemotherapy (HDC) Combined With Adoptive Cellular Therapy With DC-CIK Cells in Triple Negative Breast Cancer Patients (NCT01232062) | Peking University Cancer Hospital & Institute | 2010-08-01 |
| Study the Role of Stem Cell in Curing Drug Induced Liver Injury in Metastatic Breast Cancer (MBC) (NCT01231022) | Peking University Cancer Hospital & Institute | 2010-08-01 |
| Gene Expression Profiling of Metastatic Breast Cancer Predict the Therapeutic Response to Chemotherapy (NCT01198301) | Peking University Cancer Hospital & Institute | 2010-08-01 |
| GCC 0845:Vorinostat and Lapatinib in Advanced Solid Tumors and Advanced Breast Cancer to Evaluate Response and Biomarkers (NCT01118975) | University of Maryland, Baltimore | 2010-03-01 |
| Study to Evaluate a High Intensity Focused Ultrasound (HIFU) Procedure in Patient With Liver Metastases (NCT01489787) | Centre Leon Berard | 2010-03-01 |
| A Study of Intravenous XMT-1107 in Patients With Advanced Solid Tumors (NCT01011972) | Mersana Therapeutics | 2010-03-01 |
| Gastric Cancer Liver Metastasis Cohort of China (NCT04574245) | Chinese PLA General Hospital | 2010-01-01 |
| Combination Study of BMS-754807 and Erbitux® in Subjects With Advanced or Metastatic Solid Tumors (NCT00908024) | Bristol-Myers Squibb | 2009-10-01 |
| Pilot Study of Intra-Arterial Cisplatin With IV Thiosulfate in Patients With Lung Cancer or Lung Metastases (NCT01114958) | University of California, San Diego | 2009-09-03 |
| Safety Study of Increasing Doses of Combretasatin A1 Diphosphate (OXi4503) as Monotherapy in Subjects With Hepatic Tumor Burden (NCT00960557) | Mateon Therapeutics | 2009-07-01 |
| A Study to Test Lung Function After Radiation Therapy (NCT01039649) | University of Iowa | 2009-06-01 |
| Study of Intravenous Aflibercept in Combination With FOLFIRI in Japanese Patients With Metastatic Colorectal Cancer (NCT00921661) | Sanofi | 2009-06-01 |
| Pilot Study to Test the Feasibility and the Efficacy of the German Language Adapted PRO-SELF© Plus Pain Control Program (NCT00920504) | University Hospital, Basel, Switzerland | 2009-06-01 |
| Phase I Vorinostat Concurrent With Stereotactic Radiosurgery (SRS) in Brain Metastases From Non-Small Cell Lung Cancer (NCT00946673) | Stanford University | 2009-06-01 |
| Study of Fractionated Stereotactic Radiosurgery to Treat Large Brain Metastases (NCT00928226) | Stanford University | 2009-04-01 |
| Study of Aflibercept And Modified FOLFOX6 As First-Line Treatment In Patients With Metastatic Colorectal Cancer (NCT00851084) | Sanofi | 2009-02-01 |
| Study of Resection Combined With Stereotactic Radiosurgery for 1 to 3 Brain Metastases (NCT00904553) | University of Rochester | 2009-01-14 |
| A Safety And Efficacy Study Of The Combination Of Oral PF-00299804 And Intravenous CP-751,871 Given Every 3 Weeks (NCT00728390) | Pfizer | 2008-12-15 |
| A Pilot Trial of Itraconazole Pharmacokinetics in Patients With Metastatic Breast Cancer (NCT00798135) | Indiana University | 2008-11-01 |
| A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies (NCT00781612) | Genentech, Inc. | 2008-10-16 |
| The Role of Posterior Fossa Irradiation (PFI) Plus Stereotactic Radiosurgery (SRS) for Cerebellar Metastases (NCT00781209) | Tel-Aviv Sourasky Medical Center | 2008-10-01 |
| Health Economic Evaluation of Primovist-enhanced Liver MRI (NCT00764621) | Bayer | 2008-10-01 |
| Study to Assess Safety & Tolerability of AZD2281 in Combination With Bevacizumab in Patients With Advanced Solid Tumours (NCT00710268) | AstraZeneca | 2008-06-01 |
| Intraoperative Intraportal Chemotherapy Combined With Adjuvant Chemotherapy for Stage II and III Colorectal Cancer (NCT01972503) | Xu jianmin | 2008-06-01 |
| Study Assessing Metabolism, Excretion and Pharmacokinetics of a Poly (ADP-Ribose) Polymerase (PARP) Inhibitor in Patients With Solid Metastatic Tumours (NCT00633269) | AstraZeneca | 2008-04-01 |
| A Phase I Study of ABT-888 in Combination With Conventional Whole Brain Radiation Therapy (WBRT) in Cancer Patients With Brain Metastases (NCT00649207) | AbbVie (prior sponsor, Abbott) | 2008-03-01 |
| S-1 Versus 5-FU Bolus in Metastatic Pancreatic Cancer Patients Previously Treated With Gemcitabine-Based Regimen (NCT00602745) | Sanofi | 2008-02-01 |
| Evaluation of Pathwork Tissue of Origin (TOO) Test for Human Malignancies (NCT00977639) | Stanford University | 2008-02-01 |
| Open Label Phase 1 Dose Finding Study of TRC105 in Patients With Solid Cancer (NCT00582985) | Tracon Pharmaceuticals Inc. | 2007-12-01 |
| Aflibercept Versus Placebo in Combination With Irinotecan and 5-FU in the Treatment of Patients With Metastatic Colorectal Cancer After Failure of an Oxaliplatin Based Regimen (NCT00561470) | Sanofi | 2007-11-01 |
| Capecitabine to Prevent Recurrence of Hepatocellular Carcinoma After Curative Resection (NCT00561522) | Fudan University | 2007-11-01 |
| Aflibercept in Combination With Docetaxel in Metastatic Androgen Independent Prostate Cancer (NCT00519285) | Sanofi | 2007-08-01 |
| A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease. (NCT00478270) | Hoffmann-La Roche | 2007-06-01 |
| Phase 1, Open-label, Dose Escalation Study of TRC093, in Patients With Locally Advanced or Metastatic Solid Tumors (NCT00492830) | Tracon Pharmaceuticals Inc. | 2007-06-01 |
| Surgery Plus Intraoperative Peritoneal Hyperthermic Chemotherapy (IPHC) to Treat Peritoneal Carcinomatosis (NCT00454519) | Wuhan University | 2007-03-01 |
| Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases (NCT00440310) | Light Sciences Oncology | 2007-02-01 |
| Safety of Everolimus in Combination Therapy, in Patients With HER2-overexpressing Metastatic Breast Cancer (NCT00426530) | Novartis Pharmaceuticals | 2007-02-01 |
| Oxaliplatin, Capecitabine and Avastin for Metastatic Esophagogastric Adenocarcinoma (NCT00447330) | Duke University | 2007-02-01 |
| 5-FU, Folinic Acid and Irinotecan (FOLFIRI) Plus Cetuximab Versus FOLFIRI Plus Bevacizumab in First Line Treatment Colorectal Cancer (CRC) (NCT00433927) | PD Dr. med. Volker Heinemann | 2007-01-01 |
| TheraSphere for the Treatment of Liver Metastases (NCT00511862) | Boston Scientific Corporation | 2007-01-01 |
| Magnetic Resonance Imaging (MRI) Using Liverspecific Oral Contrast Agent in Metastatic Colorectal Cancer Patients (NCT00718055) | Copenhagen University Hospital at Herlev | 2006-11-01 |
| Study of Safety and Tolerability of Intravenous CRS-100 in Adults With Carcinoma and Liver Metastases (NCT00327652) | Anza Therapeutics, Inc. | 2006-10-01 |
| Cetuximab in Combination With Chemotherapy for the Treatment of Metastatic Colorectal Cancer (NCT01564810) | Xu jianmin | 2006-09-01 |
| Rapamycin With Grapefruit Juice for Advanced Malignancies (NCT00375245) | University of Chicago | 2006-09-01 |
| Study of Panitumumab Given First With Capecitabine and Oxaliplatin (CAPOX) and Then With Capecitabine and Radiation of the Pelvis for Treatment of Patients With Rectal Cancers That May or May Not Have Spread Beyond the Rectum (NCT00346099) | NSABP Foundation Inc | 2006-06-01 |
| Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer (NCT00377559) | Catharina Ziekenhuis Eindhoven | 2006-05-01 |
| Elaboration of a Model for Predicting Efficacy of Monoclonal Antibodies (Cetuximab and Bevacizumab) in Patients With Colorectal Cancer and Liver Metastases (NCT00327093) | Hospices Civils de Lyon | 2006-05-01 |
| Study Evaluating SKI-606 (Bosutinib) In Subjects With Breast Cancer (NCT00319254) | Pfizer | 2006-05-01 |
| BAY88-8223, Dose Finding Study in Patients With HRPC (NCT00337155) | Bayer | 2006-05-01 |
| Trastuzumab and RAD001 in Patients With Human Epidermal Growth Receptor 2 (HER-2) Overexpressing Breast Cancer (NCT00317720) | M.D. Anderson Cancer Center | 2006-04-01 |
| A Study of Epoetin Alfa Plus Standard Supportive Care Versus Standard Supportive Care Only in Anemic Patients With Metastatic Breast Cancer Receiving Standard Chemotherapy (NCT00338286) | Janssen Research & Development, LLC | 2006-03-02 |
| Phase 2 Trial of Bevacizumab in Combination With Pemetrexed (NCT00227019) | Heather Wakelee | 2006-03-01 |
| A Phase Ⅱ Study of Gemcitabine Combination With TS-1 in Patient With Advanced or Recurred Pancreatic Cancer (NCT00436423) | Korea University Anam Hospital | 2006-03-01 |
| A Pilot Study of Exercise in Patients With Docetaxel-Based Chemotherapy for Hormone Refractory Prostate Cancer (NCT00271687) | AHS Cancer Control Alberta | 2006-02-01 |
| Weekly vs. Every 2 Week vs. Every 3 Week Administration of ABI-007 (Abraxane)/Bevacizumab Combination in Metastatic Breast Cancer (NCT00281528) | Celgene | 2006-02-01 |
| A Trial of Postoperative Whole Brain Radiation Therapy vs. Salvage Stereotactic Radiosurgery Therapy for Metastasis (NCT00280475) | Haruhiko Fukuda | 2006-01-01 |
| Study of MDX-010 in Patients With Metastatic Hormone-Refractory Prostate Cancer (NCT00323882) | Bristol-Myers Squibb | 2006-01-01 |
| Capecitabine Associated With Weekly Paclitaxel in Metastatic Breast Cancer. (NCT00270491) | ARCAGY/ GINECO GROUP | 2005-12-01 |
| Using Intensity Modulated Radiation Therapy (IMRT) for Brain Metastases (NCT00328575) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2005-10-01 |
| Safety Study of 2DG With Stereotactic Radiosurgery (NCT00247403) | University of Iowa | 2005-10-01 |
| An Exploratory Pharmacogenomic Study of Monotherapy Erbitux in Subjects With Metastatic Non Small Cell Lung Carcinoma (NCT00207116) | Eli Lilly and Company | 2005-09-01 |
| Clinical Study of Previously Untreated Patients With Malignant Melanoma (NCT00232726) | Clavis Pharma | 2005-09-01 |
| Assessment of Pain and Quality of Life in Breast and Prostate Cancer Patients With Bone Metastases (NCT00434317) | Novartis | 2005-08-01 |
| A Study to Assess the Efficacy of Intravenous/Oral Bondronat (Ibandronate) in Patients With Metastatic Bone Disease Experiencing Moderate to Severe Pain (NCT00099177) | Hoffmann-La Roche | 2005-08-01 |
| Use of Cetuximab for Unresectable or Metastatic Esophageal and Gastric Cancer (NCT00130689) | Dana-Farber Cancer Institute | 2005-07-01 |
| Oxaliplatin and Cetuximab in First-line Treatment of Metastatic Colorectal Cancer (mCRC) (NCT00125034) | Merck KGaA, Darmstadt, Germany | 2005-07-01 |
| Using Positron Emission Tomography to Evaluate the Effects of Bevacizumab on Intra-tumoral Pharmacokinetics of 5-fluorouracil in Metastatic Colorectal Cancer (NCT00165568) | Dana-Farber Cancer Institute | 2005-07-01 |
| A Study to Assess the Efficacy of Intravenous Bondronat (Ibandronate) in Patients With Malignant and Painful Bone Disease (NCT00099203) | Hoffmann-La Roche | 2005-07-01 |
| Metastatic Gastric Cancer FFCD 03-07 (NCT00374036) | University Hospital, Toulouse | 2005-06-01 |
| Study of Oxaliplatin, Capecitabine, and Bevacizumab to Treat Older Patients With Colorectal Cancer (NCT00120172) | Geriatric Oncology Consortium | 2005-05-01 |
| Comparison Study of WBRT and SRS Alone Versus With Temozolomide or Erlotinib in Patients With Brain Metastases of NSCLC (NCT00268684) | Tel-Aviv Sourasky Medical Center | 2005-05-01 |
| Phase I, Pharmacokinetic, Pharmacodynamic Trial of PTK787 and Paclitaxel in Combination for Advanced Solid Tumors (NCT00731861) | Indiana University | 2005-05-01 |
| Characterization of Brain Metastases (NCT00184275) | Norwegian University of Science and Technology | 2005-05-01 |
| A Research Study of CP-724,714 in Patients With HER2 Overexpressing Metastatic Breast Cancer (NCT00102895) | Pfizer | 2005-04-01 |
| Safety and Efficacy Study of INGN 241 Gene Therapy in Patients With In Transit Melanoma (NCT00116363) | Introgen Therapeutics | 2005-03-01 |
| Study of Bevacizumab, Erlotinib, FOLFOX for Patients With Untreated Metastatic Colorectal Cancer (NCT00116506) | Dana-Farber Cancer Institute | 2005-01-01 |
| Proton MR Spectroscopy of Brain Metastases in Evaluation of Treatment Response. (NCT00184288) | Norwegian University of Science and Technology | 2004-11-01 |
| Effect of Zoledronic Acid in Patients With Renal Cell Cancer and Bone Metastasis (NCT00172003) | Novartis Pharmaceuticals | 2004-09-01 |
| MAD in Cancer Patients: Safety of BMS-582664 in Patients With Advanced or Metastatic Solid Tumors (NCT00207103) | Bristol-Myers Squibb | 2004-09-01 |
| Cetuximab Plus Biweekly Capecitabine and Oxaliplatin in KRAS Wild Type Metastatic Colorectal Cancer (NCT00444678) | NYU Langone Health | 2004-06-01 |
| Study Evaluating CCI-779 and Letrozole in Post-menopausal Women With Breast Cancer (NCT00083993) | Wyeth is now a wholly owned subsidiary of Pfizer | 2004-05-01 |
| Study of the Litx™ System Combined With Chemotherapy in Patients With Colorectal Liver Metastases (NCT00083785) | Light Sciences LLC | 2004-05-01 |